Vaccination Schedule in Flux: Newborn Hep B Shots Under Review
Vaccination Schedule in Flux: Newborn Hep B Shots Under Review
Advisers to Health Secretary RFK Jr. weigh changes to the childhood vaccine schedule, including delaying Hep B shots for some newborns. The move could shape access and timing.
A federal vaccine panel, appointed by Health Secretary Robert F. Kennedy Jr., is weighing significant revisions to the childhood immunization schedule. In particular, members are expected to discuss delaying Hepatitis B shots for infants whose mothers test negative for the virus. The announcements come as the panel reviews new data and questions whether the current timing best protects newborns while balancing practical considerations for clinics and families.
Supporters of a revised schedule point to potential gains in aligning vaccine timing with maternal status and reducing unnecessary early-life injections. Critics, however, warn that any changes could sow confusion among parents and healthcare providers, and may affect timely protection against preventable diseases. The committee vote this week will be closely watched for signals about how quickly such changes could be implemented and what safeguards would accompany them.
Beyond Hep B, the discussions aim to clarify the overall evidence base for the schedule and its real-world impact on access to vaccines. In a moment when public trust and logistical challenges intersect, the panel faces questions about equity, consistency across states, and how to communicate new timing to families. If the panel approves alterations, federal guidance would follow, shaping practice across hospitals and clinics in the coming months.
Cover image source: Will All Newborns Still Receive Hepatitis B Shots? A Committee’s Vote Will Tell. 🔗
